FABLYSE

Serial Number 88194104
Registration 5842986
700

Registration Progress

Application Filed
Nov 14, 2018
Under Examination
Approved for Publication
Jun 11, 2019
Published for Opposition
Jun 11, 2019
Registered
Aug 27, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20190827) (Grace Period Filing)
Due: Feb 27, 2026 Grace Period - 28 days
Original deadline was Aug 27, 2025 (overdue)

Trademark Image

FABLYSE

Basic Information

Serial Number
88194104
Registration Number
5842986
Filing Date
November 14, 2018
Registration Date
August 27, 2019
Published for Opposition
June 11, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 27, 2019
Registration
Registered
Classes
005

Rights Holder

ENDO OPERATIONS LIMITED

24
Address
FIRST FLOOR, MINERVA HOUSE
SIMMONSCOURT ROAD
BALLSBRIDGE 4
IE

Ownership History

Endo Pharmaceuticals Inc.

Original Applicant
03
Malvern, PA

Endo Pharmaceuticals Inc.

Owner at Publication
03
Malvern, PA

Endo Pharmaceuticals Inc.

Original Registrant
03
Malvern, PA

ENDO OPERATIONS LIMITED

New Owner After Registration #1
24
BALLSBRIDGE IE

Legal Representation

Attorney
Camille M. Miller

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20190827)
Due Date
August 27, 2025
Grace Period Ends
February 27, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Aug 27, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 28, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 1, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 22, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 3, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Aug 27, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 11, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 11, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 22, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 6, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 19, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 19, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 19, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 19, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 19, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 19, 2019 GNRT O NON-FINAL ACTION E-MAILED Loading...
Apr 19, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 2, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 2, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 31, 2019 ALIE A ASSIGNED TO LIE Loading...
Mar 26, 2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Feb 22, 2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 22, 2019 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Feb 22, 2019 CNSL R SUSPENSION LETTER WRITTEN Loading...
Feb 19, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 2, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 17, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Drug substances, namely, enzymes; pharmaceutical preparations for the treatment of cellulite

Classification

International Classes
005